Skip to main content
Erschienen in: European Radiology 10/2007

01.10.2007 | Hepatobiliary-Pancreas

Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media

verfasst von: Carlo Bartolozzi, Laura Crocetti, Riccardo Lencioni, Dania Cioni, Clotilde Della Pina, Daniela Campani

Erschienen in: European Radiology | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

The development and progression of a hepatocellular carcinoma (HCC) in a chronically diseased liver, i.e., the carcinogenesis, comprise a multistep and long-term process. Morphologically, this process is associated with the presence of distinct nodular lesions in the liver that are called ‘preneoplastic lesions.’ These preneoplastic lesions are associated with and can precede the growth and progression of well-differentiated HCCs . The characterization of nodular lesions and demonstration of the multistep development of HCC in the cirrhotic liver by imaging modalities represent a challenging issue. The arterial hypervascular supply, depicted by different dynamic studies, represents a fundamental radiological criterion for the diagnosis of HCC in cirrhosis. Magnetic resonance (MR) imaging performed with tissue-specific contrast media can help to investigate the “grey area” of carcinogenesis, in which significant histological changes are already present without any imaging evidence of neoangiogenesis. The purpose of this review is to provide information on the properties of tissue-specific MR contrast agents and on their usefulness in the demonstration of the pathologic changes that take place at the level of the biliary and reticuloendothelial systems during the carcinogenetic process in liver cirrhosis.
Literatur
1.
2.
Zurück zum Zitat Russo MW, Wei JT, Thiny MT et al (2004) Digestive and liver disease statistics, 2004. Gastroenterology 126:1448–1453PubMedCrossRef Russo MW, Wei JT, Thiny MT et al (2004) Digestive and liver disease statistics, 2004. Gastroenterology 126:1448–1453PubMedCrossRef
3.
Zurück zum Zitat Yeh SH, Chen PJ, Shau WY et al (2001) Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 121:699–709PubMedCrossRef Yeh SH, Chen PJ, Shau WY et al (2001) Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 121:699–709PubMedCrossRef
4.
Zurück zum Zitat Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannsch P (1997) Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Archiv 431:391–406PubMedCrossRef Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannsch P (1997) Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Archiv 431:391–406PubMedCrossRef
5.
Zurück zum Zitat Borzio M, Roncalli M, Trere D, Derenzini M (1998) Preneoplastic cellular changes in liver. Hepatology 28:1435–1436PubMedCrossRef Borzio M, Roncalli M, Trere D, Derenzini M (1998) Preneoplastic cellular changes in liver. Hepatology 28:1435–1436PubMedCrossRef
6.
Zurück zum Zitat Saeki R, Nagai H, Kaneko S et al (2000) Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol 33:99–105PubMedCrossRef Saeki R, Nagai H, Kaneko S et al (2000) Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol 33:99–105PubMedCrossRef
7.
Zurück zum Zitat Semelka RC, Helmberger TK (2001) Contrast agents for MR imaging of the liver. Radiology 278:27–38 Semelka RC, Helmberger TK (2001) Contrast agents for MR imaging of the liver. Radiology 278:27–38
8.
Zurück zum Zitat MacSween RNM, Burt AD, Portmann BC, Scheuer PJ, Anthony PP (2001) Pathology of the liver, 4th edn. Churchill Livingstone, London MacSween RNM, Burt AD, Portmann BC, Scheuer PJ, Anthony PP (2001) Pathology of the liver, 4th edn. Churchill Livingstone, London
9.
Zurück zum Zitat Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRef Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRef
10.
Zurück zum Zitat Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236PubMedCrossRef Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236PubMedCrossRef
11.
Zurück zum Zitat Lencioni R, Cioni D, Crocetti L, Della Pina MC, Bartolozzi C (2004) Magnetic resonance imaging of liver tumors. J Hepatol 40:162–171PubMedCrossRef Lencioni R, Cioni D, Crocetti L, Della Pina MC, Bartolozzi C (2004) Magnetic resonance imaging of liver tumors. J Hepatol 40:162–171PubMedCrossRef
12.
Zurück zum Zitat Kiernan F (1833) The anatomy and physiology of the liver. Philos Trans R Sic Lond 123:711–770CrossRef Kiernan F (1833) The anatomy and physiology of the liver. Philos Trans R Sic Lond 123:711–770CrossRef
13.
Zurück zum Zitat Rappaport AM, Borowy ZJ, Lough WM, Lotto WN(1954) Subdivision of heaxagonal liver lobules into a structural and functional unit. Role in hepatic physiology and pathology. Anat Rec 119:11–34PubMedCrossRef Rappaport AM, Borowy ZJ, Lough WM, Lotto WN(1954) Subdivision of heaxagonal liver lobules into a structural and functional unit. Role in hepatic physiology and pathology. Anat Rec 119:11–34PubMedCrossRef
14.
Zurück zum Zitat Matsumoto T, Kawakami M (1982) The unit-concept of hepatic parenchyma-a re-examination based on angiorchitectural studies. Acta Pathol Jpn 32:285–314PubMed Matsumoto T, Kawakami M (1982) The unit-concept of hepatic parenchyma-a re-examination based on angiorchitectural studies. Acta Pathol Jpn 32:285–314PubMed
15.
Zurück zum Zitat Ekataksin W, Wake K (1997) New concepts in biliary and vascular anatomy of the liver. In: Boyer JL, Ockner RK (eds) Proress in liver disease, vol XV. WB Saunders, Philadelphia, pp 1–30 Ekataksin W, Wake K (1997) New concepts in biliary and vascular anatomy of the liver. In: Boyer JL, Ockner RK (eds) Proress in liver disease, vol XV. WB Saunders, Philadelphia, pp 1–30
16.
Zurück zum Zitat Ishak KG, Goodman ZD, Stocker JT (1999) Atlas of tumor pathology: tumors of the liver and intrahepatic bile ducts. 3rd series, fascicle 31. Armed Forces Institute of Pathology,Washington, DC Ishak KG, Goodman ZD, Stocker JT (1999) Atlas of tumor pathology: tumors of the liver and intrahepatic bile ducts. 3rd series, fascicle 31. Armed Forces Institute of Pathology,Washington, DC
17.
Zurück zum Zitat Anthony PP (1989) Liver tumors: an update. In: Anthony PP, MacSween RMM (eds) Recent advances in histopathology, no 14. Chuchill Livingstone, Edinburgh, pp 185–203 Anthony PP (1989) Liver tumors: an update. In: Anthony PP, MacSween RMM (eds) Recent advances in histopathology, no 14. Chuchill Livingstone, Edinburgh, pp 185–203
18.
Zurück zum Zitat Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M (1996) Patomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 24:807–812PubMedCrossRef Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M (1996) Patomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 24:807–812PubMedCrossRef
19.
Zurück zum Zitat Rojkind M (1988) Fibrosis and cirrhosis as alterations in homeostasis of the liver ecosystem. In: Gitnick G (ed) Principles and practice of gastroenterology and hepatology. Elsevier, New York, pp 1121–1134 Rojkind M (1988) Fibrosis and cirrhosis as alterations in homeostasis of the liver ecosystem. In: Gitnick G (ed) Principles and practice of gastroenterology and hepatology. Elsevier, New York, pp 1121–1134
20.
Zurück zum Zitat International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993 International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993
21.
Zurück zum Zitat Roncalli M (2004) Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience. Liver Transpl 10:S9–S15PubMedCrossRef Roncalli M (2004) Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience. Liver Transpl 10:S9–S15PubMedCrossRef
22.
Zurück zum Zitat Maggioni M, Coggi G, Cassani B et al (2000) Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology 32:942–946PubMedCrossRef Maggioni M, Coggi G, Cassani B et al (2000) Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology 32:942–946PubMedCrossRef
23.
Zurück zum Zitat Sun M, Eshleman JR, Ferrell LD et al (2001) An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36–p34 region. Hepatology 33:1415–1424PubMedCrossRef Sun M, Eshleman JR, Ferrell LD et al (2001) An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36–p34 region. Hepatology 33:1415–1424PubMedCrossRef
24.
Zurück zum Zitat Tornillo L, Carafa V, Sauter G et al (2002) Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 82:547–853PubMedCrossRef Tornillo L, Carafa V, Sauter G et al (2002) Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 82:547–853PubMedCrossRef
25.
Zurück zum Zitat Terasaki S, Kanedo S, Kobayashi K, Nonamoura A, Nakanuma Y (1998) Histological features predicting malignant transformation of non-malignant hepatocellular nodules: a prospective study. Gastroenterology 115:1216–1222PubMedCrossRef Terasaki S, Kanedo S, Kobayashi K, Nonamoura A, Nakanuma Y (1998) Histological features predicting malignant transformation of non-malignant hepatocellular nodules: a prospective study. Gastroenterology 115:1216–1222PubMedCrossRef
26.
Zurück zum Zitat Theise N (1995) Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical consideration. Sem Liver Dis 15:360–371CrossRef Theise N (1995) Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical consideration. Sem Liver Dis 15:360–371CrossRef
27.
Zurück zum Zitat Seki S, Sakaguchi H, Kitada T et al (2000) Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Clin Cancer Res 6:3469–3473PubMed Seki S, Sakaguchi H, Kitada T et al (2000) Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Clin Cancer Res 6:3469–3473PubMed
28.
Zurück zum Zitat Borzio M, Fargion S, Borzio F et al (2003) Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 39:208–214PubMedCrossRef Borzio M, Fargion S, Borzio F et al (2003) Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 39:208–214PubMedCrossRef
29.
Zurück zum Zitat Kojiro M, Nakashima O (1999) Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 19:287–296PubMed Kojiro M, Nakashima O (1999) Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 19:287–296PubMed
30.
Zurück zum Zitat Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 18,900 necropsies. Cancer 7:462–503PubMedCrossRef Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 18,900 necropsies. Cancer 7:462–503PubMedCrossRef
31.
Zurück zum Zitat Manifold IH, Triger P, Underwod JC (1983) Kupffer cell depletion in chronic liver disease: implications for hepatic carcinogenesis. Lancet 2:431–433PubMedCrossRef Manifold IH, Triger P, Underwod JC (1983) Kupffer cell depletion in chronic liver disease: implications for hepatic carcinogenesis. Lancet 2:431–433PubMedCrossRef
32.
Zurück zum Zitat Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559–578PubMedCrossRef Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559–578PubMedCrossRef
33.
Zurück zum Zitat de Haen C, Lorusso V, Tirone P (1996) Hepatic transport of gadobenate dimeglumine in TR-rats. Acad Radiol 3:S452–S454PubMedCrossRef de Haen C, Lorusso V, Tirone P (1996) Hepatic transport of gadobenate dimeglumine in TR-rats. Acad Radiol 3:S452–S454PubMedCrossRef
34.
Zurück zum Zitat Kirchin MA, Pirovano GP, Spinazzi A (1998) Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 33:798–809PubMedCrossRef Kirchin MA, Pirovano GP, Spinazzi A (1998) Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 33:798–809PubMedCrossRef
35.
Zurück zum Zitat Spinazzi A, Lorusso V, Pirovano G, Kirchin M (1999) Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 6:282–291PubMedCrossRef Spinazzi A, Lorusso V, Pirovano G, Kirchin M (1999) Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 6:282–291PubMedCrossRef
36.
Zurück zum Zitat Spinazzi A, Lorusso V, Pirovano G, Taroni P, Kirchin M, Davies A (1998) Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Acad Radiol 5(Suppl 1):S86–S89PubMedCrossRef Spinazzi A, Lorusso V, Pirovano G, Taroni P, Kirchin M, Davies A (1998) Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Acad Radiol 5(Suppl 1):S86–S89PubMedCrossRef
37.
Zurück zum Zitat Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions in MRI. A multicenter comparison of Gd-EOB-DTPA with intraoperative findings. Radiology 230:266–275PubMedCrossRef Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions in MRI. A multicenter comparison of Gd-EOB-DTPA with intraoperative findings. Radiology 230:266–275PubMedCrossRef
38.
Zurück zum Zitat Oudkerk M, Torres CG, Song B et al (2002) Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 223:517–524PubMedCrossRef Oudkerk M, Torres CG, Song B et al (2002) Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 223:517–524PubMedCrossRef
39.
Zurück zum Zitat Petersein J, Spinazzi A, Giovagnoni A et al (2000) Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging. A multicenter phase III clinical study. Radiology 215:727–736PubMed Petersein J, Spinazzi A, Giovagnoni A et al (2000) Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging. A multicenter phase III clinical study. Radiology 215:727–736PubMed
40.
Zurück zum Zitat Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T (2004) Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol 39:80–88PubMedCrossRef Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T (2004) Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol 39:80–88PubMedCrossRef
41.
Zurück zum Zitat Ros PR, Freeny PC, Harms SE et al (1995) Hepatic MR imaging with ferumoxide: a multicentric clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196:481–488PubMed Ros PR, Freeny PC, Harms SE et al (1995) Hepatic MR imaging with ferumoxide: a multicentric clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196:481–488PubMed
42.
Zurück zum Zitat Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266–1276PubMed Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266–1276PubMed
43.
Zurück zum Zitat Kopp AF, Laniado M, Dammamm F et al (1997) MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology 204:749–756PubMed Kopp AF, Laniado M, Dammamm F et al (1997) MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology 204:749–756PubMed
44.
Zurück zum Zitat Rofsky NM, Weinreb JC, Bernardino ME, Youn SW, Lee JK, Noz ME (1993) Hepatocellular tumors: characterization with Mn-DPDP enhanced imaging. Radiology 188:53–59PubMed Rofsky NM, Weinreb JC, Bernardino ME, Youn SW, Lee JK, Noz ME (1993) Hepatocellular tumors: characterization with Mn-DPDP enhanced imaging. Radiology 188:53–59PubMed
45.
Zurück zum Zitat Ni Y, Marchal G, Zhang X et al (1993) The uptake of manganese dipyridoxaldiphosphate by chemically induced hepatocellular carcinoma in rats: a correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization. Invest Radiol 28:520–528PubMedCrossRef Ni Y, Marchal G, Zhang X et al (1993) The uptake of manganese dipyridoxaldiphosphate by chemically induced hepatocellular carcinoma in rats: a correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization. Invest Radiol 28:520–528PubMedCrossRef
46.
Zurück zum Zitat Liou J, Lee JK, Borrello JA, Brown JJ (1994) Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images. Magn Reson Imaging 12:71–79PubMedCrossRef Liou J, Lee JK, Borrello JA, Brown JJ (1994) Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images. Magn Reson Imaging 12:71–79PubMedCrossRef
47.
Zurück zum Zitat Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R (2000) MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol 10:1697–1702PubMedCrossRef Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R (2000) MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol 10:1697–1702PubMedCrossRef
48.
Zurück zum Zitat Youk JH, Lee JM, Kim CS (2004) MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents. AJR 183:1049–1054PubMed Youk JH, Lee JM, Kim CS (2004) MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents. AJR 183:1049–1054PubMed
49.
Zurück zum Zitat Murakami T, Baron RL, Peterson MS et al (1996) Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 200:69–77PubMed Murakami T, Baron RL, Peterson MS et al (1996) Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 200:69–77PubMed
50.
Zurück zum Zitat Coffin CM, Diche T, Mahfouz AE et al (1999) Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 9:444–449PubMedCrossRef Coffin CM, Diche T, Mahfouz AE et al (1999) Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 9:444–449PubMedCrossRef
51.
Zurück zum Zitat Scharitzer M, Schima W, Schober et al (2005) Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. J Comput Assist Tomogr 29:181–190PubMedCrossRef Scharitzer M, Schima W, Schober et al (2005) Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. J Comput Assist Tomogr 29:181–190PubMedCrossRef
52.
Zurück zum Zitat Vogl TJ, Hamm B, Schnell B et al (1993) Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J Magn Reson Imaging 3:51–58PubMedCrossRef Vogl TJ, Hamm B, Schnell B et al (1993) Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J Magn Reson Imaging 3:51–58PubMedCrossRef
53.
Zurück zum Zitat Hecht EM, Holland AE, Israel GM et al (2006) Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 239:438–447PubMedCrossRef Hecht EM, Holland AE, Israel GM et al (2006) Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 239:438–447PubMedCrossRef
54.
Zurück zum Zitat Pirovano G, Vanzulli A, Marti-Bonmati L et al (2000) Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR 175:1111–1120PubMed Pirovano G, Vanzulli A, Marti-Bonmati L et al (2000) Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR 175:1111–1120PubMed
55.
Zurück zum Zitat Manfredi R, Maresca G, Baron R et al (1999) Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenete dimeglumine (Gd-BOPTA). J Magn Reson Imaging 9:704–710PubMedCrossRef Manfredi R, Maresca G, Baron R et al (1999) Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenete dimeglumine (Gd-BOPTA). J Magn Reson Imaging 9:704–710PubMedCrossRef
56.
Zurück zum Zitat Grazioli L, Morana G, Caudana R et al (2000) Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 35:25–34PubMedCrossRef Grazioli L, Morana G, Caudana R et al (2000) Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 35:25–34PubMedCrossRef
57.
Zurück zum Zitat Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183:59–64PubMed Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183:59–64PubMed
58.
Zurück zum Zitat Hamm B, Staks T, Mühler A et al (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792PubMed Hamm B, Staks T, Mühler A et al (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792PubMed
59.
Zurück zum Zitat Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–67PubMed Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–67PubMed
60.
Zurück zum Zitat Reimer P, Rummeny EJ, Daldrup HE et al (1997) Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 7:257–280 Reimer P, Rummeny EJ, Daldrup HE et al (1997) Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 7:257–280
61.
Zurück zum Zitat Ni Y, Marchal G, Yu J, Muhler A, Lukito G, Baert AL (1994) Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization. J Magn Reson Imaging 4:355–363PubMedCrossRef Ni Y, Marchal G, Yu J, Muhler A, Lukito G, Baert AL (1994) Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization. J Magn Reson Imaging 4:355–363PubMedCrossRef
62.
Zurück zum Zitat Ni Y, Marchal G (1998) Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments. Top Magn Reson Imaging 9:183–195PubMedCrossRef Ni Y, Marchal G (1998) Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments. Top Magn Reson Imaging 9:183–195PubMedCrossRef
63.
Zurück zum Zitat Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234:468–478PubMedCrossRef Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234:468–478PubMedCrossRef
64.
Zurück zum Zitat Marchal G, Zhang X, Ni Y, Van Hecke P, Yu J, Baert AL (1993)Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology. Magn Reson Imaging 11:665–674PubMedCrossRef Marchal G, Zhang X, Ni Y, Van Hecke P, Yu J, Baert AL (1993)Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology. Magn Reson Imaging 11:665–674PubMedCrossRef
65.
Zurück zum Zitat Vogl TJ, Hammerstingl R, Schwarz W et al (1996) Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198:881–887PubMed Vogl TJ, Hammerstingl R, Schwarz W et al (1996) Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198:881–887PubMed
66.
Zurück zum Zitat Imai Y, Murakami T, Yoshida S et al (2000) Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32:205–212PubMedCrossRef Imai Y, Murakami T, Yoshida S et al (2000) Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32:205–212PubMedCrossRef
67.
Zurück zum Zitat Lim JH, Choi D, Cho SK et al (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669–676PubMedCrossRef Lim JH, Choi D, Cho SK et al (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669–676PubMedCrossRef
68.
Zurück zum Zitat Tang Y, Yamashita Y, Arakawa A et al (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR 172:1547–1554PubMed Tang Y, Yamashita Y, Arakawa A et al (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR 172:1547–1554PubMed
69.
Zurück zum Zitat Yamamoto H, Yamashita Y, Yoshimatsu S et al (1995) Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 196:106–112 Yamamoto H, Yamashita Y, Yoshimatsu S et al (1995) Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 196:106–112
70.
Zurück zum Zitat Kim SH, Choi D, Kim SH et al (2005) Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR 184:1069–1076PubMed Kim SH, Choi D, Kim SH et al (2005) Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR 184:1069–1076PubMed
71.
Zurück zum Zitat Pauleit D, Textor J, Bachmann R et al (2002) Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 222:73–80PubMedCrossRef Pauleit D, Textor J, Bachmann R et al (2002) Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 222:73–80PubMedCrossRef
72.
Zurück zum Zitat Kwak HS, Lee JM, Kim YK, Lee YH, Kim CS (2005) Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 15:140–147PubMedCrossRef Kwak HS, Lee JM, Kim YK, Lee YH, Kim CS (2005) Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 15:140–147PubMedCrossRef
73.
Zurück zum Zitat Simon G, Link TM, Wortler et al (2005) Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging. Eur Radiol 15:895–903PubMedCrossRef Simon G, Link TM, Wortler et al (2005) Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging. Eur Radiol 15:895–903PubMedCrossRef
74.
Zurück zum Zitat Clement O, Frija G, Chambon C et al (1991) Liver tumors in cirrhosis: experimental study with ferumoxides-enhanced MR imaging. Radiology 180:31–36PubMed Clement O, Frija G, Chambon C et al (1991) Liver tumors in cirrhosis: experimental study with ferumoxides-enhanced MR imaging. Radiology 180:31–36PubMed
75.
Zurück zum Zitat Kwak HS, Lee JM, Kim CS (2004) Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Eur Radiol 14:447–457PubMedCrossRef Kwak HS, Lee JM, Kim CS (2004) Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Eur Radiol 14:447–457PubMedCrossRef
76.
Zurück zum Zitat Bhartia B, Ward J, Guthrie JA, Robinson PJ (2003) Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR 180:577–584PubMed Bhartia B, Ward J, Guthrie JA, Robinson PJ (2003) Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR 180:577–584PubMed
77.
Zurück zum Zitat Lencioni R, Cioni D, Della Pina C, Crocetti L, Bartolozzi C (2005) Imaging diagnosis. Semin Liver Dis 25:162–170PubMedCrossRef Lencioni R, Cioni D, Della Pina C, Crocetti L, Bartolozzi C (2005) Imaging diagnosis. Semin Liver Dis 25:162–170PubMedCrossRef
78.
Zurück zum Zitat Libbrecht L, Desmet V, Roskams T (2005) Preneoplastic lesions in human carcinogenesis. Liver International 25:16–27PubMedCrossRef Libbrecht L, Desmet V, Roskams T (2005) Preneoplastic lesions in human carcinogenesis. Liver International 25:16–27PubMedCrossRef
79.
Zurück zum Zitat Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal capillarization in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662PubMedCrossRef Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal capillarization in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662PubMedCrossRef
Metadaten
Titel
Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media
verfasst von
Carlo Bartolozzi
Laura Crocetti
Riccardo Lencioni
Dania Cioni
Clotilde Della Pina
Daniela Campani
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 10/2007
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-007-0602-5

Weitere Artikel der Ausgabe 10/2007

European Radiology 10/2007 Zur Ausgabe

Interpretation Corner

A rare case of coma (2007: 10a)

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.